Philips buys ADAC to exploit high growth PET market
This article was originally published in Clinica
Philips Medical Systems is to expand its imaging range with the $426 million acquisition of ADAC Laboratories, the nuclear medicine and radiation therapy systems company. Philips will pay $18.50 per share for each outstanding ADAC share. The deal represents a premium on ADAC's closing price of $18.13.